Delta Corp share price: The company’s net profit slipped 68 per cent on a year-on-year (Y-o-Y) basis to Rs 21.7 crore
Posts in category Business Standard
Delta Corp down over 5% on weak June quarter results; profit slips 68% (10-07-2024)
Delta Corp share price: The company’s net profit slipped 68 per cent on a year-on-year (Y-o-Y) basis to Rs 21.7 crore
RVNL spurts on bagging multiple orders of Rs 390 cr (10-07-2024)
Rail Vikas Nigam (RVNL) surged 6.56% to Rs 578.80 after the company announced that it has secured multiple orders worth Rs 390.21 crore.
RVNL spurts on bagging multiple orders of Rs 390 cr (10-07-2024)
Rail Vikas Nigam (RVNL) surged 6.56% to Rs 578.80 after the company announced that it has secured multiple orders worth Rs 390.21 crore.
Global gold ETFs lose $6.7bn in 2024; worst H1 drop in 11 years: WGC (10-07-2024)
WGC defines gold ETFs as regulated securities that hold gold in physical form. These include open-ended funds traded on regulated exchanges and other regulated products like closed-end funds and MFs
Bansal Wire Inds makes stellar debut; shares trade at 33% premium over issue price (10-07-2024)
Share of Bansal Wire Industries were currently trading at Rs 340.95 on the BSE, implying a premium of 33.18% as compared to the stock’s issue price of Rs 256.
Mankind Pharma rallies 5% after 3.7 mn shares change hands via block deal (10-07-2024)
Mankind Pharma, the domestic pharmaceutical major’s stock price surged up to 5.27 per cent at Rs 2,215 per share on the BSE in Wednesday’s intraday trade
Mankind Pharma rallies 5% after 3.7 mn shares change hands via block deal (10-07-2024)
Mankind Pharma, the domestic pharmaceutical major’s stock price surged up to 5.27 per cent at Rs 2,215 per share on the BSE in Wednesday’s intraday trade
Emcure Pharma makes strong debut on NSE; lists at 31% premium over issue price (10-07-2024)
Shares of Emcure Pharmaceuticals were currently trading at Rs 1,350 on the NSE, implying a premium of 33.93% as compared to the stock’s issue price of Rs 1,008.
Emcure Pharma makes strong debut on NSE; lists at 31% premium over issue price (10-07-2024)
Shares of Emcure Pharmaceuticals were currently trading at Rs 1,350 on the NSE, implying a premium of 33.93% as compared to the stock’s issue price of Rs 1,008.